FDA Drug Recalls

Recalls / Class I

Class ID-1829-2015

Class I— FDA's most serious classification, issued when there is a reasonable probability that use of or exposure to the drug will cause serious adverse health consequences or death.

Product

Prolotherapy with Phenol (Dextrose 25%, Glycerin 10%, Lidocaine HCl 10%, Bupivacaine HCl 0.625%, Phenol 1%, QS SWI), 5 mL vial, Rx Only, Hartley Medical, (888) 671-2888

Affected lot / code info
Lot: RX # 323132, Exp. 10/06/2015; RX # 328690, Exp. 12/1/2015

Why it was recalled

Non-Sterility: Hartley Medical Center Pharmacy, Inc. is recalling Prolotherapy with Phenol due to non-sterility concerns.

Recalling firm

Firm
Hartley Medical Center Pharmacy, Incorporated
Notification channel
Press Release
Type
Voluntary: Firm initiated
Address
113 W Victoria St, N/A, Long Beach, California 90805-2162

Distribution

Quantity
14 vials
Distribution pattern
CA and NV

Timeline

Recall initiated
2015-08-17
FDA classified
2015-09-25
Posted by FDA
2015-10-07
Terminated
2015-12-30
Status
Terminated

Source: openFDA Drug Enforcement endpoint. Recall record D-1829-2015. The FDA issues recall classifications as health-hazard assessments, not legal findings; for legal claims consult a licensed attorney.

Class I recall: drug · FDA Drug Recalls